Last reviewed · How we verify

NCT03676816

Self Sampling for Rapid Turnaround Testing in the Emergency Department

Completed NA Last updated 5 August 2021
What this trial tests

NA trial testing vaginal self sampling in Chlamydia Trachomatis in 533 participants. Completed in 9 June 2020.

Timeline
17 September 2018
Primary endpoint
9 June 2020
9 June 2020

Quick facts

Lead sponsorUniversity of California, San Francisco
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment533
Start date17 September 2018
Primary completion9 June 2020
Estimated completion9 June 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Francisco

Who can join

18 and older, female only, with Chlamydia Trachomatis or Neisseria Gonorrhoeae. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Consenting adult female patient felt by the provider to require gonorrhea/chlamydia endocervical testing will be asked to provide an additional self sample specimen. The specimen will be sent to the laboratory using conventional diagnostic test for gonorrhea/chlamydia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chlamydia Trachomatis

Currently open trials in the same condition.

Other University of California, San Francisco trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03676816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing